<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[biotechnology and ivax corp. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/biotechnology+and+ivax+corp..html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to biotechnology and ivax corp.]]></description>
	<s:counts start="0" returned="4" found="4" />
	<language>en-us</language>
	<item>
		<title><![CDATA[IVAX To Present At The CIBC World Markets Annual Biotechnology And Specialty Pharmaceuticals Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_April_1/ai_n13496053]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) is scheduled to make a presentation Tuesday, April 5, 2005, at 4:15 PM Eastern Time at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference being held at The Millennium Broadway Hotel in New York City. Neil Flanzraich, vice chairman and president...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Apr 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Feb_4/ai_n9493201]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) is scheduled to make a presentation Tuesday, February 8, 2005, at 11:15 AM Eastern Time at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference being held at the Grand Hyatt in New York City. Neil Flanzraich, vice chairman and president of IVAX...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 04 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/medical+device.html"><![CDATA[medical device]]></category>
		<category domain="http://resources.bnet.com/topic/merrill+lynch+%2526+co.+inc..html"><![CDATA[Merrill Lynch & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MER</category>
		<category domain="tickers">IVX,MER</category>
	</item>
	<item>
		<title><![CDATA[IVAX to Present At CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference; First Quarter Earnings to be Announced On April 30, 2002]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_April_26/ai_85135085]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 26 Apr 2002 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Corporation Names Marcus Vice President, Oncology and Biotechnology]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_1999_Nov_11/ai_57516102]]></link>
		<description><![CDATA[MIAMI--BUSINESS WIRE--Nov. 11, 1999--]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 11 Nov 1999 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
</channel>
</rss>
